title: [Acquired hemophilia and rheumatoid arthritis. Value of intravenous immunoglobulins].
abstract: The authors report an exceedingly rare complication of rheumatoid arthritis, i.e. acquired hemophilia due to anti-factor VIII autoantibody production. Treatment with intravenous immune globulin ensured control of hemorrhagic manifestations by inducing a transient rise in factor VIII level.
authors.affiliation: Service de Médecine Interne, Hôtel-Dieu, Nantes.
authors.forename: L
authors.initials: L
authors.lastname: Struillou
authors.forename: M
authors.initials: M
authors.lastname: Fiks-Sigaud
authors.forename: J H
authors.initials: JH
authors.lastname: Barrier
authors.forename: E
authors.initials: E
authors.lastname: Blat
authors.forename: G
authors.initials: G
authors.lastname: Magadur-Joly
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000276:immunology; D001323:Autoantibodies / Q000302:isolation & purification; D005169:Factor VIII / Q000276:immunology; D005260:Female; D006467:Hemophilia A / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*
chemical_list: D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D005169:Factor VIII
vernacular_title: Hemophilie acquise et polyarthrite rhumatoïde. Intérêt des immunoglobulines intra-veineuses.